Genedrive’s (GDR) “Buy” Rating Reiterated at Peel Hunt

Peel Hunt reissued their buy rating on shares of Genedrive (LON:GDR) in a report published on Tuesday morning, ThisIsMoney.Co.Uk reports.

GDR stock opened at GBX 21.50 ($0.28) on Tuesday. The stock has a market capitalization of $7.31 million and a PE ratio of -1.54. The company’s 50-day moving average is GBX 19.22 and its 200-day moving average is GBX 18.83. Genedrive has a 1 year low of GBX 13 ($0.17) and a 1 year high of GBX 30 ($0.39).

In other news, insider Ian David Gilham bought 48,000 shares of the firm’s stock in a transaction that occurred on Friday, November 22nd. The stock was acquired at an average cost of GBX 21 ($0.27) per share, with a total value of £10,080 ($13,171.31).

About Genedrive

genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. It operates through three divisions: Preclinical Research Services, Pharmacogenomic Services, and Diagnostics.

Featured Article: Forex

Receive News & Ratings for Genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genedrive and related companies with MarketBeat.com's FREE daily email newsletter.